Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Side effects of isocarboxazid.

The Journal of Clinical Psychiatry

|July 1, 1984

Summary

This summary is machine-generated.

Isocarboxazid is an effective and safe treatment for atypical depression, according to three studies. While side effects like dizziness and dry mouth were common, they were generally mild and manageable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Performance characteristics and clinical utility of diagnostic criteria proposals in bereaved treatment-seeking patients.

Psychological medicine·2016

Same author

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.

Psychological medicine·2012

Same author

Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.

Psychological medicine·2011

Same author

Participants in the workshop.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2011

Same author

Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?

Journal of affective disorders·2010

Same author

Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.

International journal of geriatric psychiatry·2007

Area of Science:

Psychiatry
Pharmacology
Clinical Medicine

Background:

Atypical depression presents unique challenges in treatment.
Monoamine oxidase inhibitors (MAOIs) have a role in managing depressive disorders.

Purpose of the Study:

To evaluate the efficacy and safety of isocarboxazid for atypical depression.
To assess the adverse event profile of isocarboxazid in this patient population.

Main Methods:

Three double-blind, placebo-controlled studies were conducted.
Patients received isocarboxazid at doses of 40-50 mg/day.
Efficacy and safety data were collected and analyzed.

Main Results:

Isocarboxazid demonstrated efficacy in treating atypical depression.

Related Experiment Videos

Adverse events were generally mild and manageable, including dizziness and dry mouth.

Transient liver function elevations and mild blood pressure changes were observed in some patients.

Conclusions:

Isocarboxazid is a safe and efficacious option for atypical depression.
The drug is potentially underutilized in clinical practice.
Careful monitoring for side effects is recommended.